Scale Up

Aug 24, 2018
By BioPharm International Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Aug 01, 2018
BioPharm International
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jul 19, 2018
By BioPharm International Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 01, 2018
BioPharm International
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
Jun 07, 2018
By BioPharm International Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
May 30, 2018
By BioPharm International Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Apr 06, 2018
By BioPharm International Editors
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
native1_300x100
lorem ipsum